Skip to content

MRK vs WST: Dividend Comparison

MRK$143.37
Merck & Co., Inc.
Health Care
vs
WST$415.45
West Pharmaceutical Services Inc
Health Care

Dividend data as of

Merck & Co., Inc. (MRK) and West Pharmaceutical Services Inc (WST) are both in the Health Care sector, making them natural rivals for dividend investors. MRK offers a significantly higher 2.33% yield compared to WST's 0.25%, a gap of 2.08%. Both stocks show similar dividend growth rates, each around 6.0% over the past five years. Both stocks carry a "Safe" dividend safety rating. MRK is a Dividend Contender while WST is a Dividend Aristocrat.

Verdict

Best for Income
MRK
Higher yield at 2.33%
Best for Growth
Tie
Growth rates are similar
Best for Safety
MRK
Lower payout ratio (3%)

Track MRK and WST in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$143.37
$415.45
Dividend Yield
2.33%
0.25%
Annual Dividend
$3.40
$1.04
5yr Div CAGR
6.0%
5.9%
3yr Div CAGR
5.2%
6.1%
Consecutive Years
15
33
Payout Ratio
3.43%
9.88%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$233/yr
$25/yr

Yield Analysis

MRK
2.33%
WST
0.25%

MRK yields 2.08% more than WST. In dollar terms, MRK pays $3.40/share vs WST's $1.04/share annually.

Dividend Growth

MRK 5yr CAGR
6.0%
decelerating
WST 5yr CAGR
5.9%
steady

MRK: Dividend growth is slowing — the 3-year CAGR of 5.2% trails the 5-year rate of 6.0% and the 10-year rate of 6.8%.

WST: Dividend growth has been steady, with a 3-year CAGR of 6.1% and a 5-year CAGR of 5.9% (10-year: 6.5%).

Dividend Safety

MRK
Safe
Payout Ratio3%
WST
Safe
Payout Ratio10%

MRK: The payout ratio of 3% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 0.3x.

WST: The payout ratio of 10% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 8.6x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
MRK
WST
$10,000
$233/yr
$25/yr
$50,000
$1,167/yr
$125/yr
$100,000
$2,333/yr
$251/yr

What does $10,000 buy in MRK vs WST today?

At $143.37 per share, $10,000 buys about 69.7 shares of Merck & Co., Inc. (MRK). Each share pays $3.40 per year in dividends, so the position starts out generating roughly $237 per year — about $20 a month.

At $415.45 per share, $10,000 buys about 24.1 shares of West Pharmaceutical Services Inc (WST). Each share pays $1.04 per year in dividends, so the position starts out generating roughly $25 per year — about $2 a month.

MRK is the larger income stream from day one: $212 per year more on the same $10,000 invested.

What could $10,000 of MRK or WST income look like in 10 years?

Merck & Co., Inc. (MRK) has raised its dividend about 6.0% a year over the past five years. If that pace held, the $233 per year that $10,000 generates today at the current 2.33% yield would reach $418 per year by 2036 — a 4.2% yield on the original cost.

West Pharmaceutical Services Inc (WST) has raised its dividend about 5.9% a year over the past five years. If that pace held, the $25 per year that $10,000 generates today at the current 0.25% yield would reach $45 per year by 2036 — a 0.4% yield on the original cost.

On those trailing rates, MRK pays more in 2036: $418 versus $45 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would WST's dividend growth overtake MRK's higher yield?

It doesn't, on the trailing numbers. Merck & Co., Inc. (MRK) yields more today (2.33% vs 0.25%) and has also grown its dividend at least as fast (6.0% vs 5.9% a year over five years). Unless WST accelerates its raises or MRK stumbles, WST never closes the income gap — MRK wins on both current income and growth.

Can MRK and WST afford their dividends?

Merck & Co., Inc. (MRK) earns $1.00 per share against $3.40 paid out in dividends — 0.3x coverage (a 3% payout ratio).

West Pharmaceutical Services Inc (WST) earns $8.91 per share against $1.04 paid out in dividends — 8.6x coverage (a 10% payout ratio).

WST's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for MRK if earnings weaken.

Which fits an early-retirement income portfolio better, MRK or WST?

For income you need right now, Merck & Co., Inc. (MRK) leads: $100,000 invested today pays about $194 a month at the current 2.33% yield, versus $21 a month from West Pharmaceutical Services Inc (WST) at 0.25%.

On consistency: MRK has raised its dividend 15 consecutive years; WST has raised its dividend 33 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $526/yr in MRK vs $46/yr in WST by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.